Friday, 03 April 2020

Generics News

  • FDA warns Tianjin Zhongan for cGMP lapses

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2014

    Singapore: The US Food and Drug Administration (FDA) has slapped a warning letter to China based Tianjin Zhongan Pharmaceutical company for manufacturing adulterated active pharmaceutical ...Read more

  • Beximco pharma receives TFDA approval

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2014

    Singapore: Beximco pharmaceuticals, a Bangladeshi pharma giant announced that it had received Good Manufacturing Practices approval from the Taiwan Food and Drug Administration (TFDA). The ...Read more

  • Teva to acquire migraine drug firm at $825 mn

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2014

    Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmaceutical, is set to acquire biotechnology company focused on treatment...Read more

  • Mayne Pharma appoints a new vice president

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2014

    Singapore: Australian drug maker Mayne Pharma announced Mr Blake Cullen as the new vice president of business development, for its US generic products division. The company spokesperson sa...Read more

  • GSK seeks FIPB nod to hike stake in India

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jan, 2014

    Singapore: British drugmaker GlaxoSmithKline has approached the Foreign Investment Promotion Board (FIPB) to hike stake in its domestic arm by buying 24.33 percent for an estimated Rs 6,400...Read more

  • Pharma FDI cap, right move for India

    Generics |  Opinion | By Nandita Singh | 0 Comment | 31 Jul, 2012

    India's pharma industry, mainly comprising generics has got a breather. The government in India has decided to cap brownfield foreign direct investment in pharma at 49 percent, allaying fea...Read more

  • GSK CEO: London HQ 'knew nothing' of the fraud

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Addressing the global media for the first time after allegations were leveled out against Britain's largest drugmaker, GlaxoSmithKline, the company's CEO Sir (Dr) Andrew Witty ha...Read more

  • FDA nod for Lupin's angina generic Ranolazine

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Mumbai: Lupin Phamaceuticals has received final approval for its Ranolazine extended-release tablets, 500 mg and 1000 mg from the US FDA. Lupin's Ranolazine extended-release tablets are th...Read more

  • Eli Lilly files $500 mn suit against Canada govt

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

    Singapore: Eli Lilly has filed a $500 million international lawsuit against the Canadian government alleging that the country's courts unfairly threw out these patents when challenged by ge...Read more

  • DRL launches Alchemia thrombosis generic in India

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2013

    Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic anti-coagulant product fondaparinux in India. This is the first time fo...Read more

  • Abbott Laboratories unveils strategy for India

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: Pharma major Abbott Laboratories has unveiled its strategy for the Indian market, claiming that it will push its best brands and focus on nutrition and over-the-counter drug port...Read more

  • Pfizer to acquire Innopharma at $360 mn

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2014

    Singapore: Global pharma firm, Pfizer, plans to acquire InnoPharma at approx $360 million to strengthen its generics, injectable and ophthalmic products. InnoPharma's current portfolio inc...Read more

  • Mylan launches operations in India with 18 ARV products

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2012

    Bangalore: Mylan Pharmaceuticals, a subsidiary of Mylan, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) produ...Read more

  • Mundipharma appoints John Lee as GM for SEA

    Generics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

    Singapore: Asian pharmaceutical firm, Mundipharma, has promoted the general manager of Mundipharma Korea, Mr John Lee, to the position of general manager for South Korea and South East Asia...Read more

  • Dr Reddy's launches Eszopiclone tablets in US

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2014

    Singapore: Dr Reddy's Laboratories has launched sedative drug, Eszopiclone tablets (C-IV) 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTA (eszopiclone) tablets C-IV...Read more

  • Bioscience firms queue up for Japan market

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into an aging society. A survey by the country's Ministry of Internal Affai...Read more

  • FDA clears 152 antiretroviral drugs for HIV/AIDS program

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

    Singapore: The US Food and Drug Administration (FDA) has approved or tentatively approved a total of 152 antiretroviral drugs in association with the President's Emergency Plan for AIDS Rel...Read more

  • Wockhardt gets FDA nod for generic treatment of enlarged prostate

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2012

    Mumbai: Pharmaceutical and biotechnology major Wockhardt has received final approval from the US Food & Drug Administration (US FDA) for marketing 10mg extended release tablets of Alfuz...Read more